Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate c...

por Shore, Neal, Higano, Celestia S., George, Daniel J., Sternberg, Cora N., Saad, Fred, Tombal, Bertrand, Miller, Kurt, Kalinovsky, Jan, Jiao, XiaoLong, Tangirala, Krishna, Sartor, Oliver
Publicado 2020

Interim analysis of the REASSURE (Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC popUlation for long-teRm Evaluation) study: patient characteristics and s...

por Dizdarevic, Sabina, Petersen, Peter Meidahl, Essler, Markus, Versari, Annibale, Bourre, Jean-Cyril, la Fougère, Christian, Valdagni, Riccardo, Paganelli, Giovanni, Ezziddin, Samer, Kalinovský, Ján, Bayh, Inga, Du, Yong
Publicado 2019